MedPath

A study to compare the effect of HYDRASTININUM MURIATICUM and HOMOEOPATHIC CONSTITUTIONAL MEDICINE on improving quality of life of patients with UTERINE FIBROID

Phase 3
Conditions
Health Condition 1: D25- Leiomyoma of uterus
Registration Number
CTRI/2023/11/059969
Lead Sponsor
Dr Dilna KP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with signs and symptoms of Uterine fibroid

2.Patients of uterine fibroid with USG findings.

3.Women of age 20-50 years

4.Fibroid size upto 7cm

Exclusion Criteria

1.Pregnant and lactating women

2.Hb < 7 gldl

3.Complications of fibroid like torsion (immediate surgical management)

4.Patients with adenomyosis, ovarian tumors and uterine cysts.

5.Extra- uterine fibroid, polyp, cervical fibroid and any fibroid causing hydronephrosis

6.Malignancy of genitourinary tract or history of any malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment assessed by The Uterine Fibroid Symptoms and Quality of Life (UFS-QOL) questionnaireTimepoint: Each case will be reviewed at 14-21 days interval and will be followed up to a period of maximum 1 year
Secondary Outcome Measures
NameTimeMethod
comparison of quality of life in patients receiving homoeopathic constitutional medicine and Hydrastininum muriaticum in various potenciesTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath